61 related articles for article (PubMed ID: 8619951)
1. Blocking of CD4 cell receptors for the human immunodeficiency virus type 1 (HIV-1) by chemically modified bovine milk proteins: potential for AIDS prophylaxis.
Neurath AR; Debnath AK; Strick N; Li YY; Lin K; Jiang S
J Mol Recognit; 1995; 8(5):304-16. PubMed ID: 8619951
[TBL] [Abstract][Full Text] [Related]
2. Novel, negatively charged, human serum albumins display potent and selective in vitro anti-human immunodeficiency virus type 1 activity.
Jansen RW; Schols D; Pauwels R; De Clercq E; Meijer DK
Mol Pharmacol; 1993 Nov; 44(5):1003-7. PubMed ID: 7902528
[TBL] [Abstract][Full Text] [Related]
3. Synthetic CD4 exocyclics inhibit binding of human immunodeficiency virus type 1 envelope to CD4 and virus replication in T lymphocytes.
Zhang X; Gaubin M; Briant L; Srikantan V; Murali R; Saragovi U; Weiner D; Devaux C; Autiero M; Piatier-Tonneau D; Greene MI
Nat Biotechnol; 1997 Feb; 15(2):150-4. PubMed ID: 9035140
[TBL] [Abstract][Full Text] [Related]
4. Charge modification of plasma and milk proteins results in antiviral active compounds.
Swart PJ; Harmsen MC; Kuipers ME; Van Dijk AA; Van Der Strate BW; Van Berkel PH; Nuijens JH; Smit C; Witvrouw M; De Clercq E; de Béthune MP; Pauwels R; Meijer DK
J Pept Sci; 1999 Dec; 5(12):563-76. PubMed ID: 10628656
[TBL] [Abstract][Full Text] [Related]
5. Antiviral effects of milk proteins: acylation results in polyanionic compounds with potent activity against human immunodeficiency virus types 1 and 2 in vitro.
Swart PJ; Kuipers ME; Smit C; Pauwels R; deBéthune MP; de Clercq E; Meijer DK; Huisman JG
AIDS Res Hum Retroviruses; 1996 Jun; 12(9):769-75. PubMed ID: 8738428
[TBL] [Abstract][Full Text] [Related]
6. Identification of N-phenyl-N'-(2,2,6,6-tetramethyl-piperidin-4-yl)-oxalamides as a new class of HIV-1 entry inhibitors that prevent gp120 binding to CD4.
Zhao Q; Ma L; Jiang S; Lu H; Liu S; He Y; Strick N; Neamati N; Debnath AK
Virology; 2005 Sep; 339(2):213-25. PubMed ID: 15996703
[TBL] [Abstract][Full Text] [Related]
7. Structural basis for the interaction between focal adhesion kinase and CD4.
Garron ML; Arthos J; Guichou JF; McNally J; Cicala C; Arold ST
J Mol Biol; 2008 Feb; 375(5):1320-8. PubMed ID: 18078954
[TBL] [Abstract][Full Text] [Related]
8. How can (-)-epigallocatechin gallate from green tea prevent HIV-1 infection? Mechanistic insights from computational modeling and the implication for rational design of anti-HIV-1 entry inhibitors.
Hamza A; Zhan CG
J Phys Chem B; 2006 Feb; 110(6):2910-7. PubMed ID: 16471901
[TBL] [Abstract][Full Text] [Related]
9. Bile salt-stimulated lipase from human milk binds DC-SIGN and inhibits human immunodeficiency virus type 1 transfer to CD4+ T cells.
Naarding MA; Dirac AM; Ludwig IS; Speijer D; Lindquist S; Vestman EL; Stax MJ; Geijtenbeek TB; Pollakis G; Hernell O; Paxton WA
Antimicrob Agents Chemother; 2006 Oct; 50(10):3367-74. PubMed ID: 17005819
[TBL] [Abstract][Full Text] [Related]
10. Inducible-costimulator-mediated suppression of human immunodeficiency virus type 1 replication in CD4(+) T lymphocytes.
Zhou X; Kubo M; Nishitsuji H; Kurihara K; Ikeda T; Ohashi T; Azuma M; Masuda T; Kannagi M
Virology; 2004 Aug; 325(2):252-63. PubMed ID: 15246265
[TBL] [Abstract][Full Text] [Related]
11. Lewis X component in human milk binds DC-SIGN and inhibits HIV-1 transfer to CD4+ T lymphocytes.
Naarding MA; Ludwig IS; Groot F; Berkhout B; Geijtenbeek TB; Pollakis G; Paxton WA
J Clin Invest; 2005 Nov; 115(11):3256-64. PubMed ID: 16239964
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of coreceptor-independent cell-to-cell human immunodeficiency virus type 1 transmission by a CD4-immunoglobulin G2 fusion protein.
Bosch B; Blanco J; Pauls E; Clotet-Codina I; Armand-Ugón M; Grigorov B; Muriaux D; Clotet B; Darlix JL; Esté JA
Antimicrob Agents Chemother; 2005 Oct; 49(10):4296-304. PubMed ID: 16189111
[TBL] [Abstract][Full Text] [Related]
13. [Chemokine receptors and its importance in the replication cycle of human immunodeficiency virus: clinical and therapeutic implications].
Azevedo-Pereira JM; Santos-Costa Q
Acta Med Port; 2008; 21(5):497-504. PubMed ID: 19187693
[TBL] [Abstract][Full Text] [Related]
14. Functional design of potential inhibitors of human immunodeficiency virus (HIV) binding to CD4+ target cells: a molecular model of gp120 predicts ligand binding.
Gabriel JL; Mitchell WM
Drug Des Discov; 1996 Oct; 14(2):103-14. PubMed ID: 9010617
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and optimization of peptidomimetics as HIV entry inhibitors against the receptor protein CD4 using STD NMR and ligand docking.
Neffe AT; Bilang M; Meyer B
Org Biomol Chem; 2006 Sep; 4(17):3259-67. PubMed ID: 17036114
[TBL] [Abstract][Full Text] [Related]
16. SPC3, a V3 loop-derived synthetic peptide inhibitor of HIV-1 infection, binds to cell surface glycosphingolipids.
Delézay O; Hammache D; Fantini J; Yahi N
Biochemistry; 1996 Dec; 35(49):15663-71. PubMed ID: 8961929
[TBL] [Abstract][Full Text] [Related]
17. Modulation of specific surface receptors and activation sensitization in primary resting CD4+ T lymphocytes by the Nef protein of HIV-1.
Keppler OT; Tibroni N; Venzke S; Rauch S; Fackler OT
J Leukoc Biol; 2006 Mar; 79(3):616-27. PubMed ID: 16365153
[TBL] [Abstract][Full Text] [Related]
18. Critical role of Arg59 in the high-affinity gp120-binding region of CD4 for human immunodeficiency virus type 1 infection.
Fontenot D; Jones JK; Hossain MM; Nehete PN; Vela EM; Dwyer VA; Jagannadha Sastry K
Virology; 2007 Jun; 363(1):69-78. PubMed ID: 17320923
[TBL] [Abstract][Full Text] [Related]
19. Identification of HIV-1 epitopes that induce the synthesis of a R5 HIV-1 suppression factor by human CD4+ T cells isolated from HIV-1 immunized hu-PBL SCID mice.
Yoshida A; Tanaka R; Kodama A; Yamamoto N; Ansari AA; Tanaka Y
Clin Dev Immunol; 2005 Dec; 12(4):235-42. PubMed ID: 16584108
[TBL] [Abstract][Full Text] [Related]
20. Structural and functional analysis of negatively charged milk proteins with anti-HIV activity.
Berkhout B; Derksen GC; Back NK; Klaver B; de Kruif CG; Visser S
AIDS Res Hum Retroviruses; 1997 Sep; 13(13):1101-7. PubMed ID: 9282815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
